» Articles » PMID: 16612635

Intraretinal and Periretinal Pathology in Anterior Proliferative Vitreoretinopathy

Overview
Specialty Ophthalmology
Date 2006 Apr 14
PMID 16612635
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the intraretinal and periretinal pathological changes in early anterior proliferative vitreoretinopathy (APVR).

Design: Observational case series.

Participants: Eighteen patients undergoing retinectomy for APVR.

Methods: Retinectomy specimens removed at vitrectomy surgery were analysed by (a) semithin light microscopy, (b) immunohistochemistry and (c) electron microscopy.

Results: The specimens showed consistent outer retinal degenerative changes, marked Muller cell hypertrophy and glial continuity to epiretinal membranes. Photoreceptor outer and inner segments were markedly disrupted and occasional photoreceptor nuclear had pyknosis and chromatin clumping consistent with apoptosis. Muller cells expressed upregulated levels of glial fibrillary acid protein (GFAP) and extended through glial bridges to complex epiretinal membranes which in some areas had a bilaminar structure with a glial-negative inner lamina.

Conclusion: Retinal degeneration and photoreceptor apoptosis occur in retinal detachment complicated by proliferative vitreoretinopathy (PVR), although during the early stages of the process neural retinal cells remain present, suggesting potential for recovery. The intraretinal glial response appears to be centrally involved in the formation of contractile epiretinal membranes. The retina retains the capacity for a degree of functional recovery following surgery for PVR. Surgical separation of anterior epiretinal membranes in PVR may be difficult and incomplete and alternative surgical strategies may be necessary to prevent recurrence.

Citing Articles

ABCA4 mediated traumatic proliferative vitreoretinopathy associated with PI3K/Akt signaling pathway.

Menghua W, Hu Z Heliyon. 2024; 10(7):e27024.

PMID: 38560110 PMC: 10980942. DOI: 10.1016/j.heliyon.2024.e27024.


A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study.

Charteris D, Cro S, Casswell E, Tudor Edwards R, Ezeofor V, Anthony B Health Technol Assess. 2023; 27(12):1-50.

PMID: 37840322 PMC: 10591211. DOI: 10.3310/GNBJ1387.


Managing PVR in the Era of Small Gauge Surgery.

Nagpal M, Juneja R, Talati S J Ophthalmol. 2021; 2021:8959153.

PMID: 34904057 PMC: 8665895. DOI: 10.1155/2021/8959153.


[Proliferative vitreoretinopathy process-To heal or not to heal].

Grisanti S, Priglinger S, Hattenbach L Ophthalmologe. 2020; 118(1):10-17.

PMID: 33326054 DOI: 10.1007/s00347-020-01294-0.


Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy.

Lee S, Surbeck J, Drake M, Saunders A, Jin H, Shah V Invest Ophthalmol Vis Sci. 2020; 61(5):22.

PMID: 32413125 PMC: 7405623. DOI: 10.1167/iovs.61.5.22.


References
1.
Charteris D, Sethi C, Lewis G, Fisher S . Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye (Lond). 2002; 16(4):369-74. DOI: 10.1038/sj.eye.6700194. View

2.
Snead M, Snead D, Richards A, Harrison J, Poulson A, Morris A . Clinical, histological and ultrastructural studies of the posterior hyaloid membrane. Eye (Lond). 2002; 16(4):447-53. DOI: 10.1038/sj.eye.6700198. View

3.
McGillem G, Dacheux R . Migration of retinal microglia in experimental proliferative vitreoretinopathy. Exp Eye Res. 1998; 67(3):371-5. DOI: 10.1006/exer.1998.0526. View

4.
McLeod D, Hiscott P, Grierson I . Age-related cellular proliferation at the vitreoretinal juncture. Eye (Lond). 1987; 1 ( Pt 2):263-81. DOI: 10.1038/eye.1987.46. View

5.
Diddie K, Azen S, Freeman H, Boone D, AABERG T, Lewis H . Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology. 1996; 103(7):1092-9. DOI: 10.1016/s0161-6420(96)30562-9. View